Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus.
Eugene KrustevJohn G HanlyRicky ChinKatherine A BuhlerMurray B UrowitzCaroline GordonSang-Cheol BaeJuanita Romero-DiazJorge Sánchez-GuerreroSasha BernatskyDaniel J WallaceDavid IsenbergAnisur RahmanJoan T MerrillPaul R FortinDafna D GladmanIan N BruceMichelle A PetriEllen M GinzlerMary Anne DooleyRosalind Ramsey-GoldmanSusan ManziAndreas JönsenGraciela S AlarcónRonald F Van VollenhovenCynthia AranowMeggan MackayGuillermo Ruiz-IrastorzaSung Sam LimMurat InancKenneth C KalunianSøren JacobsenChristine A PeschkenDiane L KamenAnca AskenaseJill BuyonMarvin J FritzlerAnn E ClarkeMay Yee ChoiPublished in: Lupus science & medicine (2024)
Anti-KIF20B is a potential biomarker for SLE-related CN. Further studies are needed to examine how autoantibodies against KIF20B, which is variably expressed in a variety of neurological cells, contribute to disease pathogenesis.